Classification	Medications
Conventional synthetic DMARDs	Hydroxychloroquine (Plaquenil) Sulfasalazine (Azulfidine) Methotrexate Leflunomide (Arava)
Biologic DMARDs	Tumor necrosis factor inhibitors  Adalimumab (Humira)  Certolizumab pegol (Cimzia)  Etanercept (Enbrel)  Golimumab (Simponi)  Infliximab (Remicade)
	T cell costimulatory inhibitor  Abatacept (Orencia)
	Interleukin-6 receptor inhibitors  Sarilumab (Kevzara)  Tocilizumab (Actemra)
	Anti-CD20 antibodies  Anakinra (Kineret)*  Rituximab (Rituxan)
Targeted synthetic DMARDs	Janus kinase inhibitors  Baricitinib (Olumiant)  Tofacitinib (Xeljanz)  Upadacitinib (Rinvoq)